Viral and host mediators of non-suppressible HIV-1 viremia
-
Published:2023-11-13
Issue:12
Volume:29
Page:3212-3223
-
ISSN:1078-8956
-
Container-title:Nature Medicine
-
language:en
-
Short-container-title:Nat Med
Author:
Mohammadi Abbas, Etemad Behzad, Zhang Xin, Li YijiaORCID, Bedwell Gregory J., Sharaf Radwa, Kittilson Autumn, Melberg Meghan, Crain Charles R., Traunbauer Anna K., Wong Colline, Fajnzylber JesseORCID, Worrall Daniel P.ORCID, Rosenthal Alex, Jordan Hannah, Jilg NikolausORCID, Kaseke Clarety, Giguel Francoise, Lian Xiaodong, Deo Rinki, Gillespie Elisabeth, Chishti Rida, Abrha Sara, Adams Taylor, Siagian Abigail, Dorazio Dominic, Anderson Peter L., Deeks Steven G.ORCID, Lederman Michael M., Yawetz Sigal, Kuritzkes Daniel R., Lichterfeld Mathias D.ORCID, Sieg ScottORCID, Tsibris AtheORCID, Carrington MaryORCID, Brumme Zabrina L., Castillo-Mancilla Jose R., Engelman Alan N.ORCID, Gaiha Gaurav D., Li Jonathan Z.ORCID
Abstract
AbstractNon-suppressible HIV-1 viremia (NSV) is defined as persistent low-level viremia on antiretroviral therapy (ART) without evidence of ART non-adherence or significant drug resistance. Unraveling the mechanisms behind NSV would broaden our understanding of HIV-1 persistence. Here we analyzed plasma virus sequences in eight ART-treated individuals with NSV (88% male) and show that they are composed of large clones without evidence of viral evolution over time in those with longitudinal samples. We defined proviruses that match plasma HIV-1 RNA sequences as ‘producer proviruses’, and those that did not as ‘non-producer proviruses’. Non-suppressible viremia arose from expanded clones of producer proviruses that were significantly larger than the genome-intact proviral reservoir of ART-suppressed individuals. Integration sites of producer proviruses were enriched in proximity to the activating H3K36me3 epigenetic mark. CD4+ T cells from participants with NSV demonstrated upregulation of anti-apoptotic genes and downregulation of pro-apoptotic and type I/II interferon-related pathways. Furthermore, participants with NSV showed significantly lower HIV-specific CD8+ T cell responses compared with untreated viremic controllers with similar viral loads. We identified potential critical host and viral mediators of NSV that may represent targets to disrupt HIV-1 persistence.
Funder
U.S. Department of Health & Human Services | National Institutes of Health Harvard University Center for AIDS Research U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases supported by a Scholar Award from Michael Smith Health Research BC Burroughs Wellcome Career Award for Medical Scientists This Research was supported in part by the Intramural Research Program of the NIH, Frederick National Lab, Center for Cancer Research
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference103 articles.
1. Halvas, E. K. et al. HIV-1 viremia not suppressible by antiretroviral therapy can originate from large T cell clones producing infectious virus. J. Clin. Invest. 130, 5847–5857 (2020). 2. Laprise, C., de Pokomandy, A., Baril, J. G., Dufresne, S. & Trottier, H. Virologic failure following persistent low-level viremia in a cohort of HIV-positive patients: results from 12 years of observation. Clin. Infect. Dis. 57, 1489–1496 (2013). 3. Ryscavage, P., Kelly, S., Li, J. Z., Harrigan, P. R. & Taiwo, B. Significance and clinical management of persistent low-level viremia and very-low-level viremia in HIV-1-infected patients. Antimicrob. Agents Chemother. 58, 3585–3598 (2014). 4. Redd, A. D. et al. ART adherence, resistance, and long-term HIV viral suppression in postpartum women. Open Forum Infect. Dis. 7, ofaa346 (2020). 5. Dharan, N. J. & Cooper, D. A. Long-term durability of HIV viral load suppression. Lancet HIV 4, e279–e280 (2017).
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|